Page last updated: 2024-11-07

quin2-acetoxymethyl ester

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Quin2-AM is a cell-permeable acetoxymethyl ester derivative of the calcium chelator Quin2. It is widely used as a fluorescent indicator for intracellular calcium concentration. Upon entry into cells, Quin2-AM is hydrolyzed by intracellular esterases to release the active form, Quin2, which binds to calcium ions. The binding of calcium to Quin2 causes a change in the fluorescent properties of the molecule, allowing for the measurement of intracellular calcium levels using fluorescence microscopy or flow cytometry. Quin2-AM is commonly used to study calcium signaling in various cell types, including neurons, muscle cells, and immune cells. It has been instrumental in understanding the role of calcium in a wide range of cellular processes, including muscle contraction, neurotransmission, and cell signaling. The use of Quin2-AM has contributed to the development of important insights into the mechanisms of calcium homeostasis and its physiological significance.'

Quin2-acetoxymethyl ester: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID105103
MeSH IDM0109308

Synonyms (19)

Synonym
quin 2-am, >=90%
quin 2am
quin 2-am
83104-85-2
acetyloxymethyl 2-[n-[2-(acetyloxymethoxy)-2-oxoethyl]-2-[[8-[bis[2-(acetyloxymethoxy)-2-oxoethyl]amino]-6-methoxyquinolin-2-yl]methoxy]-4-methylanilino]acetate
quin-2 acetoxymethyl ester
8ef0c5h59d ,
quin2-acetoxymethyl ester
quin2-am
glycine, n-(2-((acetyloxy)methoxy)-2-oxoethyl)-n-(2-((8-(bis(2-((acetyloxy)methoxy)-2-oxoethyl)amino)-6-methoxy-2-quinolinyl)methoxy)-4-methylphenyl)-, (acetyloxy)methyl ester
unii-8ef0c5h59d
quin2 acetoxymethyl ester [mi]
quin2 acetoxymethyl ester
DTXSID10232173
HY-101902
quin-2am
CS-7702
Q27270255
AKOS040744110

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The guanylate cyclase inhibitor methylene blue (10 microM), on the other hand, shifted the dose-response curves for renin release and cGMP levels to 100-fold higher concentrations of ANP."( Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process.
Bauer, C; Della Bruna, R; Kurtz, A; Pfeilschifter, J; Taugner, R, 1986
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (172)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990141 (81.98)18.7374
1990's27 (15.70)18.2507
2000's4 (2.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 8.77

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index8.77 (24.57)
Research Supply Index5.18 (2.92)
Research Growth Index3.95 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (8.77)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews7 (3.98%)6.00%
Case Studies1 (0.57%)4.05%
Observational0 (0.00%)0.25%
Other168 (95.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]